Trial record 1 of 1 for:
RedHill | NTM
RHB-204 for the Treatment of Pulmonary Mycobacterium Avium Complex Disease (CleaR-MAC)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04616924 |
Recruitment Status :
Recruiting
First Posted : November 5, 2020
Last Update Posted : April 1, 2021
|
Sponsor:
RedHill Biopharma Limited
Information provided by (Responsible Party):
RedHill Biopharma Limited
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Recruiting |
---|---|
Estimated Primary Completion Date : | August 2022 |
Estimated Study Completion Date : | July 2023 |